We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 2.78% | 7.40 | 6.70 | 7.50 | 7.24 | 6.90 | 7.10 | 444,115 | 16:35:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 55.2M | -40.22M | -0.0084 | -8.45 | 343.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/1/2023 21:04 | We shall see. | red army | |
01/1/2023 12:00 | But it might not come back. If they can't get any funding and the accounts can't get signed off then what? Or there could be a placing dilution of shares below the current price..hopefully it's above the current price if that happens. Basically there's no certainty of anything. You could either be a genius for selling off all your shares at 5p, or a genius for buying them at 5p. Time will tell. | amishp67 | |
01/1/2023 10:29 | HAPPY 2023 TO ALL. | wizzkid211 | |
31/12/2022 16:48 | It was a one off opportunity to buy yesterday before suspension I believe. Just wondering whether accounts issue was designed to play this out??? Just saying. | red army | |
31/12/2022 14:58 | Something will happen for sure and soon. As the shares are going to bd suspended I got out. Will watch and wait now. | raleigh43 | |
31/12/2022 14:03 | Its a guess as a minor shareholder but the two biggest shareholders are in the driving seat. A good time to buy IMO | red army | |
31/12/2022 13:51 | I hope not @ 15p :( | amishp67 | |
30/12/2022 20:39 | Looks like it did an AGY | amishp67 | |
30/12/2022 12:30 | Well that's that..for now | amishp67 | |
30/12/2022 12:29 | I should think so, the prices is nuts. | jimmyloser | |
30/12/2022 10:14 | doubt it very much. look him up. Works for Abbott in acquisition. | genises | |
29/12/2022 20:02 | £17 million was for costs of trials for 2023. The begging bowl is out as the bank wont bank role them for the loss of 3rd party contracts and 5 weeks of loss production which will have a effect in company profits for 2023. Plus cost of new production equipment. Question is why did they not stock pile before hand knowing production will stop in the near future. Where was the forward planning to pay for the equipment which they needed to replace. | genises | |
29/12/2022 19:44 | What a complete shambles. What on earth are these clowns doing? Nothing makes sense. There's no reasoning behind any of this. Have the directors just been clumsy and just made continuous errors. Why is there no explanation as to what has happened. They have money in the bank and they raised 17million recently. Do they need more? And why? What exactly is the issue here..they need to explain it to us. This is unacceptable! | amishp67 | |
29/12/2022 18:39 | If the company cant find short term funds then the for sale sign will have to go up. Bye bye all Directors. Question why will the companies bank not lend the money at a fixed rate of 10%. The non exc Directors should earn their money and hold the directors at the top responsible for the shambles of the last 3 months. Who should go. The major shareholder must be livid 32p to 5p with so much bad news since the fund raising. Heads need to go starting with the CEO. | genises | |
29/12/2022 17:11 | Yes, but that's all our testicles ... :-( | sunshine band | |
29/12/2022 14:03 | Some may say that they deserve to have their testicles in a vice! | jimmyloser | |
29/12/2022 13:51 | Anybody needing cash in this market will negotiate with their testacles in a vice. TWD was trading at 13p and then announced a 1p placing out of the blue. GLA | onedayrodders |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions